CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
In this Phase I study safety of the combination of Docetaxel and Temsirolimus needs to be
shown before the study can be expanded into a Phase II study to examine the activity of a
safe combination of Temsirolimus and Docetaxel in a comparison with Docetaxel alone.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Central European Society for Anticancer Drug Research